NeoGenomics, Inc. Payments of Stock Issuance Costs
NeoGenomics, Inc. (NEO) reported Payments of Stock Issuance Costs of $10.30 million for the 1-month period ending 2019-05-31, per its 10-K filed 2021-02-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2021-02-25
- NeoGenomics, Inc. payments of stock issuance costs for the quarter ending 2018-06-30 was $576.00K.
- NeoGenomics, Inc. payments of stock issuance costs for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- NeoGenomics, Inc. payments of stock issuance costs for the quarter ending 2017-09-30 was $85.00K.
- NeoGenomics, Inc. payments of stock issuance costs for the quarter ending 2017-06-30 was $0.00.
| Period end | Payments of Stock Issuance Costs 1 month | Payments of Stock Issuance Costs 1 month as first filed | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month |
|---|---|---|---|---|---|
| 2019-05-31 | $10.30M 10-K · filed 2021-02-25 | ||||
| 2018-08-31 | $8.60M 10-K · filed 2020-02-28 | ||||
| 2018-06-30 | $576.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $576.00K 10-Q · filed 2018-08-06 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-08 | ||||
| 2017-09-30 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $85.00K derived: sum of 2 quarters · filed 2018-08-06 | $197.00K 10-Q · filed 2017-11-13 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $112.00K 10-Q · filed 2018-08-06 | |||
| 2017-03-31 | $112.00K 10-Q · filed 2018-05-08 | ||||
| 2016-03-31 | $97.00K 10-Q · filed 2017-05-09 | ||||
| 2014-08-31 | $2.70M 10-K · filed 2017-03-14 | $2.50M 10-Q · filed 2014-11-04 | |||
| 2013-03-31 | $800.00K 10-K · filed 2016-04-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |